You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Guidelines & Advice

About Guidelines Email Guidelines Team

Displaying Guidelines

30 Items

Systemic Treatments for Unresectable and Metastatic Cutaneous Melanoma

Document Status: Current
ID: GL 8-12

Updated

Jan 2026

T-Cell Engaging Antibodies: Management of Cytokine Release Syndrome (CRS) and Immune Effector-Associated Neurotoxicity Syndrome (ICANS)

Document Status: Current

Mar 2025

The Role of Trastuzumab (Herceptin) in the Treatment of Women with HER2/neu-overexpressing Metastatic Breast Cancer

Document Status: Archived
ID: 1-15 Version 3
Version: 3

Sep 2011

The Role of Trastuzumab in Adjuvant and Neoadjuvant Therapy in Women with HER2/neu-overexpressing Breast Cancer

Document Status: Education and Information
ID: 1-24 Version 2
Version: 2

May 2006

The Use of Targeted Therapies in Patients with Inoperable Locally Advanced or Metastatic Renal Cell Cancer: Updated Guideline 2017

Document Status: In-Review
ID: 3-8-4
Version: 2

May 2017

Treatment of Multiple Myeloma: ASCO–Ontario Health (Cancer Care Ontario) Living Guideline

Document Status: Current
ID: GL 6-A-2023-1
Version: 2

Updated

Jan 2026